Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ernexa Therapeutics
AddedFeb 19, 2024
UpdatedJul 4, 2026
Ernexa Therapeutics

Ernexa Therapeutics

Public

Eterna Therapeutics: Pioneering cell engineering for cancer and immunologic disease treatment.

HQ
Cambridge, MA, US
Founded
1984
Overview
Compare
Fundraising
Employees
Website

Eterna Therapeutics is a biotechnology company focused on unlocking the power of cell engineering for curative and transformative therapies. The company leverages its robust intellectual property portfolio to develop and out-license technology platforms aimed at providing new medicines for patients with cancer and immunologic diseases. Eterna's approach explores the potential of the human immune system in treatment, both as a standalone therapy and in combination with other approaches.

The company's mission is to redefine possibilities in cellular and gene therapy, with a current focus on co-developing and out-licensing its proprietary technology platforms. Eterna Therapeutics aims to deliver transformational new medicines to patients, positioning itself at the forefront of innovative cell engineering solutions for complex diseases.

Ernexa Therapeutics - Similar Companies

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Cellular Approaches logo

Cellular Approaches

Mana Therapeutics logo

Mana Therapeutics

Cartesian Therapeutics logo

Cartesian Therapeutics

Thymmune Therapeutics logo

Thymmune Therapeutics

thymmune.com

CERo Therapeutics logo

CERo Therapeutics

cero.bio

Century Therapeutics logo

Century Therapeutics

centurytx.com

LTZ Therapeutics logo

LTZ Therapeutics

Aleta Biotherapeutics logo

Aleta Biotherapeutics

aletabio.com

Kyverna Therapeutics logo

Kyverna Therapeutics

Vita Therapeutics logo

Vita Therapeutics

HebeCell logo

HebeCell

hebecellcorp.com

Seneca Therapeutics logo

Seneca Therapeutics

Immunitas Therapeutics logo

Immunitas Therapeutics

immunitastx.com

Modulus Therapeutics logo

Modulus Therapeutics

Ernexa Therapeutics - Quick Facts

Who are Ernexa Therapeutics' competitors?

Companies similar to Ernexa Therapeutics include Cell BioEngines, Cellular Approaches, Mana Therapeutics and Cartesian Therapeutics.

When was Ernexa Therapeutics founded?

Ernexa Therapeutics was founded in 1984.

Where is Ernexa Therapeutics' headquarters located?

Ernexa Therapeutics' headquarters is located in Cambridge, MA, US.

When was Ernexa Therapeutics' last funding round?

Ernexa Therapeutics' most recent funding round was for $9.2M (USD) in December 2023.

How much has Ernexa Therapeutics raised to-date?

As of Dec 14, 2023, Ernexa Therapeutics has raised a total of $49.1M (USD).

How many employees does Ernexa Therapeutics have?

Ernexa Therapeutics has 11 employees as of Feb 5, 2024.

Ernexa Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
Customer
  • Enterprise
Main Product
  • Cell Therapies
Tags
  • Healthtech
Unique IDs
  • secCik: 0000748592
  • ticker: ERNA
  • ticker: ERNAW
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 22 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 516000Broadcasting and Content Providers
  • 516100Radio and Television Broadcasting Stations
  • 516120Television Broadcasting Stations
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4830Radio And Television Broadcasting Stations
  • 4833Television Broadcasting Stations
  • 4000Railroad Transportation
  • 4800Communications
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research